Investigating joint issues in patients with Gitelman Syndrome
The Osteoarticular Manifestations in Patients With Gitelman Syndrome
Second Affiliated Hospital, School of Medicine, Zhejiang University · NCT06922370
This study is trying to see if people with Gitelman Syndrome also have joint problems caused by calcium deposits and how these issues can be managed.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 120 (estimated) |
| Sex | All |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University (other) |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Trial ID | NCT06922370 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients who have been clinically and genetically confirmed to have Gitelman Syndrome. It aims to screen these patients for calcium pyrophosphate deposition disease (CPPD) and collect both clinical and radiographic data to analyze the osteoarticular manifestations associated with the syndrome. The methodology involves using conventional radiographs or computed tomography to assess the joint conditions in these patients. By understanding the relationship between Gitelman Syndrome and CPPD, the study seeks to provide insights into the management of joint-related symptoms in affected individuals.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals who have been clinically and genetically confirmed to have Gitelman Syndrome.
Not a fit: Patients with other conditions such as Bartter Syndrome or hyperparathyroidism may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of joint complications in Gitelman Syndrome, leading to better management strategies for patients.
How similar studies have performed: While this study addresses a specific aspect of Gitelman Syndrome, similar studies investigating osteoarticular manifestations in other conditions have shown promising results, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients confirmed with Gitelman Syndrome Exclusion Criteria: * Patients with other confounding situations such as Bartter Syndrome, hyperparathyroidism
Where this trial is running
Hangzhou, Zhejiang
- the second affiliated hospital, Zhejiang University School of medicine — Hangzhou, Zhejiang, China (RECRUITING)
Study contacts
- Study coordinator: Lijun Mou
- Email: moulj511@zju.edu.cn
- Phone: +86-0571-89713751
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Gitelman Syndrome, CPPD - Calcium Pyrophosphate Deposition Disease